Project Grant HT94252410274
- This $676,117 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital of Philadelphia (CHOP) Research Institute. The funding supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the grant will fund research on "EXPANDED GAA-GGA CHIMERIC REPEATS IN FRIEDREICH ATAXIA," a neurological disorder, over...
- The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
- This $356,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of a novel gene therapy for mitochondrial complex I deficiency at the Children's Hospital of Philadelphia (CHOP). The award period runs from March 1, 2024 to February 28, 2026. CHOP, a leading pediatric hospital and research institution, will leverage its expertise in areas like rare genetic disorders to advance this innovative...
- The Defense Health Agency awarded a $1,746,810 Project Grant to The Children's Hospital of Philadelphia (CHOP) on July 1, 2025, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the research project "Combination Therapy for High-Risk, MYCN-Amplified Neuroblastoma" which aims to develop innovative medical solutions to address critical health challenges for military personnel and the broader public. The research will be...
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $356,000.00 to The Children's Hospital of Philadelphia (CHOP) to study the impact on ketosis phenotype. The performance period for this award is from Sep 1, 2024 to Aug 31, 2026. As a leading pediatric research institution, CHOP leverages its expertise in areas such as genetic disorders and neurological conditions to contribute to...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,273,300 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in a mouse model of Friedreich's ataxia. The grant, with a performance period from September 1, 2024 to August 31, 2028, will support CHOP's pioneering research efforts to advance understanding and treatment of this...
- The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,984,636 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in Friedreich's ataxia mice. The grant, awarded on September 1, 2024, will support this research project over a 4-year period until August 31, 2028. As a leading pediatric research institution, CHOP will leverage...
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $326,712.00 to The Children's Hospital of Philadelphia (CHOP) to conduct research on structured lipid nutrition intervention and its impact on symptom management and quality of life. The project aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. CHOP, a renowned pediatric...
- The Children's Hospital of Philadelphia (CHOP) was awarded a $1,676,839 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support CHOP's research efforts from July 2022 through July 2026 to overcome dedifferentiation of pediatric thyroid cancer through molecularly targeted therapy. The Military Medical Research and Development program aims to transform military and public health...
- The U.S. Defense Health Agency awarded a $1,751,725 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME" from September 1, 2023 to August 31, 2027. CHOP, a pediatric hospital and research center, will use this funding from the Military Medical Research and Development program (CFDA 12.420) to transform health care for Service Members and the American public through innovative and impactful...
The Children's Hospital of Philadelphia (CHOP) has been awarded a $1,773,720.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. This award, with a period of performance from July 1, 2024 to June 30, 2028, will support research to elucidate the cardiomyopathy associated with the mitochondrial disorder Friedreich's ataxia. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas like genetic disorders and neurodevelopmental conditions to advance this medical research with potential to benefit military service members, veterans, and their families. The findings from this research project could lead to new treatments, diagnostic tools, or clinical practice guidelines to address this condition, which is relevant to military medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.8m | 4/4/24 |